SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Centocor ( CNTO ) -- Ignore unavailable to you. Want to Upgrade?

To: FNS who wrote (859)12/4/1998 12:07:00 PM
From: Douglas Babbin  Read Replies (1) | Respond to of 965
 
I'm am very curious why IMNX is going up so much. Is their EMBREL a better product for rheumatiod arthritis than CNTO's Remicade?



To: FNS who wrote (859)12/4/1998 12:10:00 PM
From: Biomaven  Read Replies (1) | Respond to of 965
 
I'm back in again this morning. (I exited at around 50 when the news of the Remicade reactions first broke: Message 6501567 .)

I suspected there might be an over-reaction, and I think there has been. May take some time for the stock's credibility to be re-established again, though.

Peter


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News